Flatiron Health Announces New Partnership in the UK
Expansion into UK marks company’s third international subsidiary.
Flatiron Health, an oncology-focused RWD technology company, has partnered with the Leeds Teaching Hospitals NHS Trust (LTHT), one of largest acute hospital trusts in Europe. The entry into the United Kingdom marks a major milestone in Flatiron’s expansion.
Flatiron International has subsidiaries already in Japan and Germany. Each partners with hospitals and health networks in RWD collaborations through Flatiron's local teams and infrastructure, ensuring that strict legal and regulatory requirements are met in all locations. The goal is to produce more top-quality oncology datasets for use by Flatiron’s hospital and health network partners in research collaborations and under license—with specific terms and conditions—to biopharma companies, to accelerate cancer research.
“Each Flatiron International partnership is designed to help local healthcare providers and partners generate and utilize high-quality RWD to advance oncology research and care,” said Nathan Hubbard, SVP, Flatiron’s head of corporate development and Flatiron International. He noted that the agreement was approved by the NHS Health Research Authority.
Reference: Flatiron Health Announces New Partnership in the UK, June 20, 2023.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
